期刊文献+

偏侧帕金森病患者葡萄糖代谢与多巴胺转运蛋白PET显像 被引量:9

Clinical studies of ^(18)F-FDG and ^(18)F-FP-β-CIT PET imaging in hemi-Parkinson's disease
暂未订购
导出
摘要 目的 评价葡萄糖代谢与多巴胺转运蛋白PET显像在偏侧帕金森病 (PD)患者诊断中的价值。方法 正常对照组 16例。偏侧PD患者 34例 ,Hoehn YahrⅠ~Ⅱ级。其中 16例偏侧 (右侧肢体 )PD患者进行1 8F 脱氧葡萄糖 (FDG)PET显像 ,18例偏侧 (右侧或左侧 )PD患者进行1 8F N (3 氟丙基 ) 2 β 甲酯基 3β (4′ 碘苯基 )去甲基托烷 (FP β CIT)显像 ,6例患者同时进行两种显像。静脉注射1 8F FDG 185~ 2 5 9MBq 30min后进行脑三维采集 ,结果应用感兴趣区 (ROI)半定量分析和统计参数地图 (SPM)分析。1 8F FP β CIT显像于注射后 2~ 3h进行 ,计算 (各ROI计数 -小脑计数 ) 小脑计数比值。结果 PD组与对照组比较 ,患侧肢体对侧基底节葡萄糖代谢减低 ,但差异无显著性。SPM分析结果示 ,PD患者与对照组比较 ,葡萄糖代谢减低位于左侧前额叶、中额叶、下额叶及左侧中颞叶 ,而摄取增加区域除双侧额叶中央前回、双侧顶叶楔前叶、左侧枕叶外 ,还累及左侧丘脑。偏侧PD患者豆状核后部1 8F FP β CIT摄取显著减低 ,且不仅见于症状对侧豆状核 ,同侧豆状核后部也可见摄取减低。结论 1 8F FDGPET显像对PD的早期诊断无特异性。1 8F FP β CIT可早期发现PD纹状体多巴胺转运蛋白的变化 ,有助于PD的早期诊断和鉴别诊断 ;与1 8F Objective To study the characteristics of 18F-fluorodeoxyglucose (FDG) and 18F-N-3-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane ( 18F-FP-β-CIT) PET imaging in patients with hemi-Parkinson's disease (hemi-PD) and to assess their value in early diagnosis. Methods 34 cases of hemi-PD (Hoehn and Yahr stage Ⅰ~Ⅱ)and 16 normal control subjects were selected for this study. 16 patients were performed with 18F-FDG PET imaging, 18 patients with 18F-FP-β-CIF, while 6 patients of them both 18F-FDG and 18F-FP-β-CIT. 30 min after injection of 185~259 MBq 18F-FDG, 3D brain scans were acquired. Region of interest (ROI) analysis and statistical parametric mapping (SPM) were applied. 18F-FP-β-CIT PET imaging was carried out 2~3 h post injection, and (ROI-cerebellum)/cerebellum ratio was calculated. Results In right hemi-PD, reductions in 18F-FDG metabolism were observed in the left basal ganglia compared with control group, but with no significant difference (P>0.05). The results of SPM analysis showed that a significant reduction in FDG uptake in the left superior frontal gyrus, middle frontal gyrus, inferior frontal gyrus and left middle temporal gyrus, whereas a significant increase in the bilateral precentral gyrus, superior parietal lobule, left middle occipital gyrus and left thalamus as compared with the control group. There was a significant reduction in 18F-FP-β-CIT uptake in putamen, its reduction was found not only in the contralateral putamen, but also in the ipsilateral ones, and more pronounced in the contralateral posterior putamen. Conclusions 18F-FDG PET imaging is non-specific for the early diagnosis of PD. 18F-FP-β-CIT PET imaging could find the changes of striatum dopamine transporter at early stage, therefore it was helpful for early diagnosis and differential diagnosis of PD. Combined with 18F-FDG PET imaging, the changes of local cerebral glucose metabolism in PD could also be evaluated.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2003年第4期219-221,共3页 Chinese Journal of Nuclear Medicine
基金 "十五"国家科技攻关课题基金资助 (2 0 0 1BA70 2B0 2 )
关键词 偏侧 帕金森病 葡萄糖代谢 多巴胺转运蛋白 ^18F—FDGPET显像 诊断 Parkinson disease Glucose Dopamine transporter Tomography, emission-computed FP-β-CIT Deoxyglucose
  • 相关文献

参考文献8

  • 1王丽娟,唐安戊,刘斌,郑芷萍,周晓红,乔穗宪,刘新通,詹国华,梁秀龄.帕金森病脑^(18)F-FDG PET显像临床研究[J].中华核医学杂志,2002,22(1):17-18. 被引量:15
  • 2方平,陈正平,林岩松,周翔,杜宜奎,王世真.多巴胺转运蛋白显像剂^(18)F-FP-β-CIT的制备[J].同位素,2001,14(1):6-10. 被引量:5
  • 3王新德.帕金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256-256.
  • 4Hu MTM, Taylor-Robinson SD, Chaudhuri KR, et al. Cortical dysfunction in non-demented Parkinson's disease peients: a combined ^31P-MRS and ^18F-FDG-PET study. Brain, 2000, 123: 340-352.
  • 5Eidelberg D, Moeller JR, Ishikawa T, et al. Assessment of disease severity in Parkinsonism with ^18F-fluoradeoxyglucose and PET. J Nucl Med,1995, 36: 378-383.
  • 6Chaly T, Dhawan V, Kazumata K, et al. Radiosynthesis of ^18F-N-3-fluoropropyl-2-β-carbomethoxy-3-β-(4-iodophenyl) nortropane and the first human study with positron emission tomography. Nucl Med Biol, 1996,23: 999-1004.
  • 7Kazumata K, Dhawan V, Chaly T, et al. Dopamine transporter imaging with ^18F-FPCIT and PET. J Nucl Med, 1998, 39: 1521-1530.
  • 8Kish SJ, Shannak K, Homykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson' s disease. N Engl J Med, 1988, 318: 876.

二级参考文献3

共引文献139

同被引文献73

  • 1蒋雨平,王坚,丁正同,管一晖,赵军,陈正平,项景德,苏惠琳.^(18)F-FP-CIT PET和^(99)Tc^m-TRODAT-1 SPECT纹状体DAT显像在早期诊断帕金森病中的敏感性比较[J].中国临床神经科学,2006,14(2):128-133. 被引量:4
  • 2杨琳 高英茂(译).格氏解剖学(第38版)[M].沈阳:辽宁教育出版社,1999.1787-1794.
  • 3徐德隆 陈生弟 刘振国 等.帕金森病临床新技术[M].北京:人民军医出版社,2002.18.
  • 4Brooks DJ, Frey KA, Marek KL, et al. Assessment of neuroimaging techniques as biomarkers of the progression of Parkinsoo's disease. Exp Neurol,2003, 184: S68-S79.
  • 5Jennings DJ, Seibyl J, Oakes D, et al. Clinical determinants of progressive dopamine transporter loss measured by β-CIT and SPECT. Mov Disord,2002, 17: 1104.
  • 6Brownell AL, Canales K, Chen YI, et al. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson' s disease model.Neuro Image, 2003, 20: 1064-1075.
  • 7Schmidt N, Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease. J Neurol Transm, 2001, 108: 1263-1282.
  • 8Robinson S, Freeman P, Moore C, et al. Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function.Exp Neurol, 2003, 180: 73-86.
  • 9Tanji H, Araki T, Nagasawa H, et al. Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP. Brain Res,1999, 824: 224-231.
  • 10Bezard E, Dovero S, Bioulac B, et al. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Exp Neurol, 1997, 148: 288-292.

引证文献9

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部